| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-08 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.38 | 9e-08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.38 | 3e-07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.61 | 0.0001 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.6 | 0.0001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |